Multimedia
View More
In this concise Medical Minute video, become familiar with incretins and review how currently available GLP-1 receptor agonists target multiple pathophysiologic defects in T2D.
Learn about endogenous incretins, their downstream effects, and role in type 2 diabetes.
A brief history of the discovery of incretins and how incretin-based therapies revolutionized modern diabetes care.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.